REATA PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Reata Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2022.
  • Reata Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $20.4M, a 46.9% increase year-over-year.
  • Reata Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $87.8M, a 51% increase year-over-year.
  • Reata Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $58.7M, a 3.39% increase from 2021.
  • Reata Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $56.8M, a 1.44% decline from 2020.
  • Reata Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2020 was $57.6M, a 118% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.